E-Prescribing Sample Clauses

E-Prescribing. The Contractor shall support e-Prescribing services. Much of the e-Prescribing activity is supported by prescribing providers through web and office-based applications or certified electronic health record (EHR) systems to communicate with the pharmacies. When EHR systems are used, the Contractor shall supply the EHR systems with information about member eligibility, patient history and drug formulary.
Sample 1Sample 2Sample 3See All (40)
AutoNDA by SimpleDocs
E-Prescribing. The Contractor shall support e-Prescribing services. Much of the e-Prescribing activity is supported by prescribing providers through web and office-based applications or certified electronic health record (EHR) systems to communicate with the pharmacies. When EHR systems are used, the Contractor shall supply the EHR systems with information about member eligibility, patient history and applicable PDL or drug formulary. The Contractor should consider an automated PA process using a rules-based clinical editing algorithm that integrates paid medical and pharmacy claims. The Contractor agrees to work with OMPP and the fee for service PBM to transition the pharmacy benefit back to the FFS PBM if OMPP decides to implement the FFS pharmacy benefit for Hoosier Healthwise members.
Sample 1Sample 2Sample 3See All (37)
E-Prescribing. The MCO must provide the appropriate data to the national e-prescribing network, which at a minimum will support: eligibility confirmation, PDL benefit confirmation, identification of preferred drugs that can be used in place of non-preferred drugs ("alternative drugs"), medication history, and prescription routing.
Sample 1Sample 2Sample 3See All (7)
E-Prescribing. Pharmacy shall accept prescription orders sent from Covered Entity’s electronic medical record system.
Sample 1Sample 2
E-Prescribing. Member Pharmacy shall support and comply with all electronic prescription standards, requirements, and guidance adopted by CMS, the federal Drug Enforcement Administration, and other federal and state government agencies as required by Law, when such final standards, requirements, and guidance are effective, and as such standards, requirements, and guidance may be revised from time to time, including but not limited to: (i) NCPDP SCRIPT Standard, Implementation Guide, Version 8 Release (8.1) or Version 10 Release 6 (10.6) for communications concerning prescriptions or prescription-related information between Member Pharmacy and prescribers; (ii) NCPDP SCRIPT 8.1 or 10.6 for communications concerning medication history between MedImpact, Member Pharmacy and prescribers and refill status between Member Pharmacy and prescribers; (iii) NCPDP Telecommunication Standard Specification, Version D, Release 0 (Version D.0) for communications concerning eligibility between MedImpact and Member Pharmacy; (iv) the prescriber’s NPI; and (V) additionally, for electronic prescriptions of controlled substances, The Department of Justice, Drug Enforcement Administration’s Electronic Prescriptions for Controlled Substances Final Rule, 75 FR 16236 (March 31, 2010). Without limiting the generality of the foregoing, in addition, Member Pharmacy shall ensure that all electronic prescription claims include Member Pharmacy’s and the prescribers’ NPIs (if the prescriber’s NPI is not available, another non-NPI identifier such as the prescriber’s DEA number or the prescriber’s state license number, as permitted by state Law, must be included). Also, Member Pharmacy shall use NCPDP Telecommunication Standard Version D.0 Field 419 DJ – Prescription Origin Code so that the source of origin for prescriptions filled can be identified and reported.
Sample 1
E-Prescribing. The Commonwealth intends to implement enhancements to electronic systems for prescribing, dispensing and capturing data for PBS medicines, including the development of a national consumer-centric e-Prescribing system in consultation with relevant stakeholders including Medicines Australia. Such e-Prescribing arrangements are intended to:
Sample 1
E-Prescribing. BCBSNC or its designee will support e-Prescribing transaction standards for eligibility, formulary, and medication history to allow prescribers to electronically send Members' prescriptions directly to a Network Participant from the point-of-care.
Sample 1
AutoNDA by SimpleDocs

Related to E-Prescribing

  • Prescription Claims against the Issuer or any Guarantor for the payment of principal or Additional Amounts, if any, on the Notes will be prescribed ten years after the applicable due date for payment thereof. Claims against the Issuer or any Guarantor for the payment of interest on the Notes will be prescribed five years after the applicable due date for payment of interest.

  • Labeling Upon request, Lessee will xxxx the Equipment indicating Lessor's interest with labels provided by Lessor. Lessee will keep all Equipment free from any other marking or labeling which might be interpreted as a claim of ownership.

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Subcontracting 6.1 The Grantee is responsible for the performance of its obligations under this Agreement, including in relation to any tasks undertaken by subcontractors.

  • Regulatory Responsibilities A. Marketing Authorization Applications and Regulatory Approvals – RADIUS, itself or through its Affiliates or (sub)licensees, will be responsible for preparing and submitting all Regulatory Filings, including but not limited to providing any clinical data to be submitted in the XXXx. 3M will perform all activities to support the CMC section of the Regulatory Filings, and will submit all CMC data required for the Regulatory Filings in DMFs or MAFs. All XXXx, Regulatory Filings and Regulatory Approvals in the Territory shall be owned by RADIUS, its Affiliates or (sub)licensees, and remain with RADIUS, its Affiliates or (sub)licensees. Nothing in this Agreement should be construed as transferring ownership of XXXx, Regulatory Filings or Regulatory Approvals to 3M. All 3M DMFs and MAFs referenced in the XXXx, Regulatory Filings and Regulatory Approvals shall be owned by 3M, and nothing is this Agreement should be construed as transferring ownership of such DMFs and MAFs at any time to RADIUS, its Affiliates or (sub)licensees. 3M shall grant and hereby does grant to RADIUS an exclusive (solely as to the Product and in the case of Applicator, solely for use with Product), “Right of reference or use,” as that term is defined in 21 C.F.R. § 314.3(b) (or any successor rule or analogous law recognized outside of the U.S.), with the right to grant further Rights of reference or use to its (sub)licensees and Affiliates through multiple tiers to all such DMFs and MAFs owned or controlled by 3M. The right granted in the previous sentence shall be for use with the Product, does not include any rights except as relates to the Product, and is subject to the provisions of Section 6.8 of this Agreement; for avoidance of doubt, the right granted in the previous sentence specifically excludes any right in such DMFs or MAFs with respect to or for use with anything other than Product. Other than as provided above, 3M specifically reserves all other rights in all DMFs and MAFs for all other purposes, including without limitation the “Right of reference or use” for any product. 3M will provide to RADIUS, its Affiliates or its (sub)licensees and to any specified Regulatory Authority a letter of authorization, or other such executed instrument as may be necessary under, or as RADIUS, its Affiliates or its (sub)licensees may reasonably request, to effectuate the rights of reference or use to all such DMFs and MAFs, contemplated in this Section 4.4A in order to obtain, maintain support of all XXXx, Regulatory Filings and Regulatory Approvals for Product in the Territory. 3M shall provide or cause to be provided CMC information required for RADIUS’, its Affiliates’ or its (sub)licensees’ Regulatory Filing as required by the relevant Regulatory Authority in markets or territories where DMF/MAF is not available for registration. For clarity, notwithstanding anything in this Agreement to the contrary, during the Term, 3M may redact from documents provided or made available to RADIUS, its Affiliates or its (sub)licensees, and otherwise decline to disclose or provide RADIUS, its Affiliates or its (sub)licensees access to, all confidential CMC-related data and information for Product proprietary manufacturing processes relating to such confidential CMC-related data.

  • Specific Responsibilities In addition to its overall responsibility for monitoring and providing a forum to discuss and coordinate the Parties’ activities under this Agreement, the JSC shall in particular:

  • Scope of Delegated Responsibilities (a) SELECTION OF ELIGIBLE FOREIGN CUSTODIANS. Subject to the provisions of this Section 3.2, the Foreign Custody Manager may place and maintain the Foreign Assets in the care of the Eligible Foreign Custodian selected by the Foreign Custody Manager in each country listed on Schedule A, as amended from time to time. In performing its delegated responsibilities as Foreign Custody Manager to place or maintain Foreign Assets with an Eligible Foreign Custodian, the Foreign Custody Manager shall determine that the Foreign Assets will be subject to reasonable care, based on the standards applicable to custodians in the country in which the Foreign Assets will be held by that Eligible Foreign Custodian, after considering all factors relevant to the safekeeping of such assets, including, without limitation the factors specified in Rule 17f-5(c)(1).

  • Enrollment The School shall maintain accurate and complete enrollment data and daily records of student attendance.

Time is Money Join Law Insider Premium to draft better contracts faster.